February 6-8, 2018Anaheim Convention CenterAnaheim, CA
2018 Event Content Schedule
Use the scheduling tool below to browse all the available sessions, speakers and topics at this year's event. Find the content and sessions to fit all of your educational needs and ensure you get the most out of your time at the show.
The medical device community is faced with a significant challenge: how to provide sterility assurance for sensitive combination products and biologics. In response, the industry is developing new sterilization technologies, new sterilization validation paths, and new regulatory paradigms. This session will provide an overview of a new risk-based ISO guidance document, ISO TS 19930, available to use in navigating an approval path for an alternative Sterility Assurance Level (SAL) with regulatory bodies when it is not possible to terminally sterilize a combination product or biologic with a traditional maximal SAL of 10-6.
Topics to be covered include:
Update on a recently initiated AdvaMed Interest Group focused on defining predictable regulatory pathways for sterilization of sensitive combination products and biologics
Case studies of complex combination products and sterility assurance options
Risk assessment frameworks and options for bringing valuable products to market